4//SEC Filing
Sims Karen 4
Accession 0001447028-25-000039
CIK 0001447028other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:02 PM ET
Size
328.0 KB
Accession
0001447028-25-000039
Insider Transaction Report
Form 4
Sims Karen
Chief Medical Officer
Transactions
- Sale
Common Shares
2025-02-04$3.28/sh−19,348$63,519→ 106,194 total
Footnotes (1)
- [F1]Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 9, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units.
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001984652
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:02 PM ET
- Size
- 328.0 KB